Program Information


Presented for attendees of The Liver Meeting Digital Experience™. This event/function is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC and supported by medical education grants from Eisai Inc., Exelixis, Inc., Genentech, a member of the Roche Group, and Merck & Co., Inc. This is not an official function/event of the American Association for the Study of Liver Diseases.

Saturday, November 14, 2020
7:00 PM – 8:00 PM ET
Live Webinar




Join us for a live web-based CME symposium as experts discuss recent developments in the treatment of hepatocellular carcinoma (HCC). Do not miss this opportunity to learn more about new and emerging combination strategies and receive practical guidance on their integration into clinical practice, including management of side effects.

You will hear first-hand from an experienced patient with HCC who will share his personal journey and offer a novel perspective for healthcare professionals.


Richard S. Finn, MD
Professor of Medicine, Hematology/Oncology
David Geffen School of Medicine at UCLA
Los Angeles, CA
Amit Singal, MD, MS
David Bruton Jr. Professor, Clinical Cancer Research
Professor, Medicine
Medical Director, Liver Tumor Program
Clinical Chief, Hepatology
University of Texas Southwestern
Dallas, TX
Mark Yarchoan, MD
Assistant Professor, Division of GI Malignancies
Medical Oncology Director, Liver Cancer Multidisciplinary Clinic
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins
Baltimore, MD


7:00 PM – 7:10 PM
 

Richard S. Finn, MD
7:10 PM – 7:25 PM
 

Richard S. Finn, MD; Mark Yarchoan, MD
7:25 PM – 7:35 PM
 

Amit Singal, MD, MS
7:35 PM – 7:50 PM
 

Mark Yarchoan, MD
7:50 PM – 8:00 PM
 


This activity is intended for hepatology, hematology/oncology, and other clinicians including physicians, NPs, and PAs who diagnose and manage patients with hepatocellular carcinoma (HCC).



After engaging in this activity, clinicians will be able to:

  • Develop treatment plans for patients with advanced hepatocellular carcinoma (HCC) that integrate checkpoint inhibitors and targeted synthetic agents based on their efficacy and safety data
  • Develop individualized treatment plans for patients with advanced HCC across multiple lines of therapy
  • Analyze the safety and efficacy of new and emerging combination regimens for HCC

Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points and 0 patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.



This activity is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and RMEI Medical Education, LLC.



This educational activity is supported by medical education grants from Eisai Inc., Exelixis, Inc., Genentech, a member of the Roche Group, and Merck & Co., Inc.



Statements of credit will be awarded based on the participant’s attendance, participation in the pre-/post-test, and submission of the activity evaluation form. A statement of credit will be available upon completion of an evaluation/claimed credit form. If you have questions about this CME activity, please contact AKH Inc. at tbrignoni@akhcme.com.



There is no fee for this educational activity.





Facebook  Twitter  LinkedIn

Additional educational activities offered by RMEI Medical Education, LLC can be found
at www.RMEI.com or by calling toll-free (866) 770-RMEI.